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Background: Seeking medical information can be an issue for physicians. In the specific context of medical practice, chatbots
are hypothesized to present additional value for providing information quickly, particularly as far as drug risk minimization
measures are concerned.
Objective: This qualitative study aimed to elicit physicians’ perceptions of a pilot version of a chatbot used in the context of
drug information and risk minimization measures.
Methods: General practitioners and specialists were recruited across France to participate in individual semistructured interviews.
Interviews were recorded, transcribed, and analyzed using a horizontal thematic analysis approach.
Results: Eight general practitioners and 2 specialists participated. The tone and ergonomics of the pilot version were appreciated
by physicians. However, all participants emphasized the importance of getting exhaustive, trustworthy answers when interacting
with a chatbot.
Conclusions: The chatbot was perceived as a useful and innovative tool that could easily be integrated into routine medical
practice and could help health professionals when seeking information on drug and risk minimization measures.
(J Med Internet Res 2020;22(11):e15185) doi: 10.2196/15185
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Introduction
A conversational agent, also known as a “chatbot,” is an
artificial system that can converse with a human user through
automated message exchange [1]. In order to interact in a natural
way with the user, it employs a question and answer database
[2]. Commonly used in marketing as a consumers’ guide,
chatbots also have been developed in the health field in several
applications aimed mostly towards patients [3-11]. However,
little scientific research has examined the use of conversational
agents through physicians’ viewpoints [12-15], and none have
taken into account medical information addressed to health
professionals. It has been shown that nearly all physicians use
the internet for medical information seeking [16,17] but have
to cope with an increasing flow of medical information [18].
Too much information to scan could be a barrier to respond to
a defined medical question [16,17]; thus, seeking health care
information can be an issue for physicians since their
information sources can be fragmented, incomplete, and not
easy to find [19]. Credibility of the source, relevance, unlimited
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access, speed, and ease of use are the main criteria for
information seeking among physicians [17]. A national survey
conducted in France in 2017 showed that the prescription and
delivery methods of drugs could be incorrectly followed by
health professionals, despite the risk minimization measures
campaign conducted at a national level [20]. Providing medical
information to health professionals through a conversational
agent could help to detect pharmacovigilance cases early and
to reinforce the proper intake of medication by patients. More
specifically, chatbots could be deployed as a complementary
solution to provide information about drugs with the purpose
of minimizing drug risks. In France, drug risk minimization
measures are generally recommended by the European
Pharmacovigilance Risk Assessment Committee and adapted
by the French National Agency for Medicines and Health
Products Safety (Agence Nationale de Sécurité du Médicament
et des Produits de Santé) to regulate medical practice and ensure
safe, efficient intake of drugs [21].
To improve drug information access and awareness of drug risk
minimization measures among physicians, a pilot version of a
chatbot was developed and tested. The chatbot was expected to
improve drug information access and awareness of drug risk
minimization measures. This qualitative study aimed to improve
the chatbot to meet physicians’ needs and expectations. User
participation [22] was used to elicit physicians’ perceptions of
the chatbot through the use of the pilot version. Gathering more
in-depth qualitative information on these topics may be useful




The study focused on the pilot version of a text-based chatbot
developed by an international pharmaceutical company. This
was qualitative research that employed individual, in-depth,
semistructured interviews to explore physicians’ opinions and
perceptions of a chatbot. The aim of the chatbot was to provide
quick, 24-hour access to information on drugs for physicians
to improve their medical practice and the application of
recommendations regarding drug risk minimization measures
among patients. Thus, all information provided by the chatbot
was sourced from official regulatory documents issued by
French health authorities to ensure patient security. The chatbot
was accessible online through a web browser. When logged in,
it displayed a dialog box on the right side of the screen and a
female figure in the central area. Answers provided by the
chatbot followed pre-established topics related to drugs (eg,
treatment initiation, discontinuing treatment, treatment renewal,
documentation or information that can be downloaded and
obtained by the user). When asked a question, the chatbot
provided a direct answer based on its database. When a question
was not sufficiently focused, the chatbot proposed between 2
and 4 categories related to the question. The user then had to
choose between those categories by typing the corresponding
number. When the chatbot was asked a question that was not
available in its database or not understood because of a typing
error, the user was alerted. In this latter case, the user had to
reformulate the question or ask a new question related to
pre-established topics. As a pilot version, the chatbot initially
focused on one drug. Further information can be added and
delivered when the final version is deployed; the chatbot is
meant to be used by physicians who seek quick access to
information in the presence of a patient or when preparing a
consultation.
General practitioners were approached initially as the
conversational agent was developed for this specific population.
Specialists were also approached because some of their patients
used drugs subject to risk minimization measures.
Recruitment and Participants
Participants were recruited on a voluntary basis after being
asked by email whether they were interested in “taking part in
a project that will test an innovative digital health tool.” Their
email addresses were available from a database of health
practitioners who had already participated in previous digital
epidemiological studies. The interviewer had not met the
participants before the interview. General practitioners were
recruited to represent various situations such as urban and rural
general practice. Specialists were recruited from either public
or private practice. Thematic saturation was not taken into
account since the study aimed to improve the chatbot through




Semistructured interviews were conducted during June 2018
and July 2018 and took place primarily in participants’ medical
offices. At the beginning of the interview, each participant
received a brief summary of the study from the interviewer, and
sociodemographic data (gender, age, profession, and workplace)
were collected. Interviews were scheduled for approximatively
1 hour.
To standardize the interviews, they were divided into 3 sections:
introduction, introduction of the chatbot, and conclusion.
Introduction
The introduction included knowledge about the use of drugs
and recommendations about risk minimization measures and
acceptability of a chatbot within their daily practice.
Presentation of the Chatbot
The chatbot was presented through the example of 3 preselected
input phrases based on various situations: “How to accompany
a pregnant woman taking this medicine?”, “I want to renew the
prescription of a patient.”, “Does this drug decrease the impact
of contraception?” Test sessions were conducted as follows.
After the introduction, the interviewer logged in to the chatbot
with a confidential password. In the dialog box, introductory
text was displayed and read aloud by the interviewer to explain
the purpose of the chatbot. Then, preselected input phrases were
first inputted by the interviewer to show how the chatbot
worked. Participants were then asked to try the chatbot by
searching for information on drugs as they would do during a
real consultation, using their own terminology. Questions were
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collected by the interviewer after a physician concluded the test,
but participants were left free to use the conversational agent
as much as they wanted during the rest of the interview. Since
it was a pilot version, participants did not have access to the
conversational agent before or after the interview. Moreover,
the test was different from a real-case scenario since participants
were not totally autonomous in using the chatbot and had to
share their experience with the interviewer.
Conclusion
During the conclusion, feedback was collected on the user
experience with the chatbot. Physicians were asked about the
relevance and appreciation of the tested tool as well as their
needs for and expectations of the chatbot.
Template
The interviewer followed a semistructured interview template
composed of the following themes: (1) knowledge about drug
risk minimization measures and acceptability of digital health
within their daily practice (Section 1), (2) relevance and
appreciation of the chatbot to facilitate information acquisition
(Section 3), and (3) needs for and expectations of the tested
chatbot (Section 3).
Data Analysis
Interviews were recorded using a digital audio recorder after
receiving participant agreement. They were fully transcribed
and anonymized by the interviewer. Transcripts were organized,
sorted, and coded using a systematic thematic analysis approach
[23]. Main themes were developed and identified by the authors
as patterns emerged within data [24]. Then, they were
graphically represented through the use of Visual Understanding
Environment (VUE) software. For each participant, data were
summarized in one table following the main themes identified
during the interviews. Quotations that were not related to the
chatbot were excluded from analysis. Data from each theme
were gathered in another table to proceed with the horizontal
thematic analysis by highlighting sentences expressed by
participants on each topic.
Results
Demographics
A total of 10 health professionals participated in individual,
in-depth, semistructured interviews in France.
The sample size included 8 general practitioners and 2
specialists. The average age of the participants was 51.5 years.
There were 7 men and 3 women; 6 participants worked in an
urban area only, 3 worked in a rural area only, and 1 worked in
both urban and rural areas. All participants were following
patients who needed routine drug prescriptions including risk
minimization measures.
All participants reported being vigilant about new
recommendations for prescription including risk minimization
measures before using the chatbot. Seven physicians reported
that they sought information on drugs subject to risk
minimization measures only when their patients were directly
concerned, when they were confronted with a particular case,
or when adverse events had been reported to them:
I have access to information obviously, but I get more
interested when I am confronted with the problem.
[Man, in practice for 35 years]
They considered the information on drug risk minimization
measures easy to find but fragmented. The main source of
information they reported was the internet, followed by
information from health authorities (letters, email), databases
on drugs, medical journals, and communications from
laboratories (press, visits). Exchanges with other practitioners
had also been cited as sources of information:
The easiest and most accessible information is the
summary of characteristic products, but it is in rather
indigestible to read since it’s really big. [Man, in
practice for 11 years]
Generally, I do research spontaneously. I’m looking
out on the internet when I have a question about a
treatment or when I’m not sure about a question a
patient asked me, we can look together. [Woman, in
practice for 8 years]
I get information from National Agency for Medicines
and Health Products Safety, from health authorities,
and from laboratories as well. I receive either emails
or letters. [Man, in practice for 30 years]
Central Themes
Emerged Topics
Several themes and subthemes emerged from the interviews.
The central themes were (1) achievement by man including
ergonomics and format of asking; (2) achievement by tool
including design, tone, and form of presentation; (3) content of
output including the amount of information, clarity, and
accuracy; and (4) user needs. These topics are discussed with
illustrative quotes in the following paragraphs.
Achievement by Man
In total, 52 questions were asked to the chatbot by participants.
Of the 52 questions formulated by the physicians (Multimedia
Appendix 1) during tests, 24 were answered by the pilot version
of the conversational agent. One-third of the 24 answers (7/24)
were obtained on the first try, while the other two-thirds (17/24)
needed a complementary question. Furthermore, 28 questions
were not understood by the conversational agent, and 8 questions
were not included in the conversational agent themes. Questions
addressed to the conversational agent were about prescription,
medical treatment renewal, drug side effects, drug interactions,
and records on drug products.
Some physicians judged the ergonomics favorably due to
simplicity and ease of use:
This is correct. The style is sober, quiet; it is not
aggressive. It is simple and readable. [Man, in
practice for 36 years]
Yes, it is really easy to use. The ergonomics are really
good. [Man, in practice for 11 years]
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Over half (6/10) of the participants found that the chatbot lacked
intuitiveness and fluidity to access information:
The answer is clear, but I don’t know, there is
something with the fluidity... If I compare with where
I’m usually looking for information, there is one
section for each topic, and I get instant access. Here,
the answers are too robotic. [Woman, in practice for
24 years]
I would say this is not intuitive. Everyone knows how
to use a computer. But the ergonomics... I don’t know,
there is just a login page, then the home screen. If it
is just that, there is no ergonomics. It would be nice
to have a website plan. [Male, in practice for 30 years]
The size of the dialog box was also cited as improvable:
There is a part of the screen that is not used; the
dialog box looks really small compared to the rest.
It could occupy a larger space, which would allow a
bigger typeface. [Man, in practice for 11 years]
The window to type our questions is too small. If you
enter a long sentence, you can’t see the beginning of
your sentence, which is bothering. Indeed, the window
is too small and the typeface as well. [Man, in practice
for 36 years]
Achievement by Tool
Most of the participants reported that the colors and icon of the
chatbot were too simple, but the global design was judged
serious and professional, which was appreciated:
You could give us the possibility to customize the
design by choosing between 3 or 4 different colors.
Maybe it should be a bit more cheerful. It looks
seriously made, but a little too dark. [Man, 18 years
of practice]
I like the font; it is quite nice. It looks as if everything
was made to be relatively neutral. This is good
because the tool can’t be visually aggressive during
a consultation. This is not really attractive; it is quite
neutral, but this is adapted because visual elements
catching your eyes all the time can be tiring. This is
better. [Man, in practice for 11 years]
Seven participants reported that the tone of the answers was
positive. However, the display of the answers provided by the
conversational agent needed to be more concise according to
half (5/10) of the physicians:
It speaks from a medical point of view so there is no
problem with the tone. [Man, in practice for 36 years]
It needs a display with bold characters so we can
reach key points by reading through it diagonally
[Man, in practice for 23 years]
Content of Output
The response delay from the chatbot was acceptable for 9 of 10
participants, but 5 physicians were not satisfied with the length
of the information, which was too broad to read or to access:
It is a little bit long because every time it asked me
for a clarification, it seems that it doesn’t understand.
[Woman, specialist in practice for 24 years]
This is accurate but it is too much talking. Two lines
should be enough; this is too long in my opinion.
[Woman, in practice for 24 years]
Even though all participants found the information provided by
the chatbot very clear, the main issue pointed out by physicians
was the accuracy of the answers. Obtained answers did not
provide a sufficient amount of information. Thus, even if they
trusted the provided information, it was considered as too
generic and not relevant enough:
We need clear and concise scientific information. We
need to know globally what to do; then, we translate
the information but at least it needs to be precise.
Because for now, it is a little bit general; this is too
elementary. [Man, in practice for 35 years]
The answers are understandable; it comes out
quickly; it comes out clear. The only inconvenience
is that it is not the answer I was looking for. [Man,
in practice for 18 years]
It is centered on the developers’ insight, not from a
physician’s insight. This is almost a tool for a patient
actually. Physicians have much more questions than
the chatbot can answer for now. [Man, in practice for
11 years]
User Needs
Participants identified pros and cons of the chatbot after they
tested it (Table 1). Pros were the concept, ergonomics, assistance
for diagnosis, and time savings. Cons were the natural language
comprehension issues, data security, and the threat to health
care professions.
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Table 1. Pros and cons of the chatbot.
Example excerptsObservation and examples
Pros
“In my opinion, the concept is really interesting. Why? Because this is provisioning a
tool in which we can get precise and fast information. This is a concept that seems very
interesting and very relevant to me.” [Man, in practice for 35 years]
Relevant concept: give fast and precise information
“The ergonomics, the conciseness…Yes, the shape. You call this a conversational agent;
to me, it is a good research engine.” [Man, in practice for 11 years]
Ergonomic tool: can be utilized as a research tool
“The fact that it can give answers when we have a question is interesting. That doesn’t
mean we’ll necessarily follow the answer but at least it gives a direction. Tools that can
help medical care or to diagnose, I find great.” [Woman, in practice for 24 years]
Diagnosis helping:
can provide assistance to medical care
“There are only benefits anyway. This is instantaneous, verified information. It saves us
time. A consultation is time-consuming; we need to get immediate answers. It has already
happened to me that I had to call a laboratory to get an answer, and I was told that




“The tree structure to get to the information. That is to say… If I get some information,
in what degree is it intuitive? Does it need to be questioned in a precise way, or can I ask
my questions without thinking about the formulation? Can it answer my everyday needs?”
[Man, in practice for 18 years]
Natural language comprehension issues: can be diffi-
cult to access the right information
“Of course, there is hacking. I can’t take control of a doctor, but I can get control of a
conversational agent without problems. All the security part, as powerful it can be, can
always be breached if someone intends to do it. That’s the limit.” [Man, in practice for
23 years]
Medical data issue: can be dangerous for medical data
security
“Let’s say that, in 10 years, we are told that our job will be replaced; it is a nightmare.
We studied for 10 years, not 2 years, but 10 years. If we are told that we will be replaced
by artificial intelligence, it does not make anyone dream.” [Man, in practice for 23 years]
Threatens health care professionals: a chatbot could
replace doctors
Nine participants estimated that this tool would be easily
integrated in their routine practice when fully developed,
especially if it could provide fast, trustful, easily accessible
information on a range of medical topics:
It is simple; it is practical. When it has acquired more
vocabulary, I think it will be an efficient tool.
[Woman, in practice for 8 years]
This is a tool in which we can get precise and fast
information. This is a concept that seems very
interesting and very relevant to me” [Man, in practice
for 35 years]
However, half (5/10) of the participants considered that the
chatbot did not meet their needs. The main reason was the
natural language comprehension issues:
It needs to be accurate and well-edocumented
because, during a consultation and in our daily
routine, we don’t have much time. Not having enough
time means we need to get to the point; so, we need
fast, specific information” [Man, in practice for 35
years]
If I get information, what is the degree of
intuitiveness? The machine has to adapt, because
when I’m doing my job with a patient in front of me,
I can’t be focused on how I should formulate my
question to the chatbot. [Man, in practice for 18 years]
During a consultation, everything has to be done
quickly, I need information quickly. If the chatbot
doesn’t understand me, I put it aside to get the
information elsewhere. [Woman, in practice for 24
years]
Participants reported areas to improve the chatbot prototype
(Textbox 1). Suggestions were made about the content of the
conversational agent, its display and appearance, and the
extensions of use that could be made. Suggestions included
highlighting the most important information provided by the
chatbot, the possibility to provide an information sheet to the
patients, or integrating medical themes beyond drug risk
minimization measures.
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Textbox 1. Suggestions made by general practitioners and specialists for improvement of the conversational agent.
Display and appearance
• Highlight important information in the answers
• Possibility to choose interface colors
Content
• Provide [printed] information to the patients
• Regular updates
Extensions of use
• Ask questions orally
• Integrate more themes (eg, drug interactions, pathologies)
• Declare side effects
Discussion
Principal Findings
The study was conducted to elicit physicians’ perceptions of a
chatbot that is meant to improve drug information access and
awareness of drug risk minimization measures. A qualitative
approach was chosen to collect detailed data on how the chatbot
was used and perceived by physicians on a small scale and needs
and expectations for the chatbot. As a pilot version, the chatbot
did not meet physicians’ expectations.
Overall, the findings demonstrated that physicians’ needs
towards information delivered by the chatbot were the reliability
of sources, precise information, and speed of access. This is
consistent with previous research demonstrating that all these
features are critical to physicians when seeking information
[17]. Physicians were particularly vigilant to the conversational
agent content. Even though they did appreciate getting
information on risk minimization measures and drugs, they had
difficulties accessing the right information because of natural
language understanding issues. As a tool based on artificial
intelligence, physicians also expected that the chatbot would
understand natural language. Previous research demonstrated
that over half of physicians believed that chatbots lack the
intelligence or knowledge to accurately assess the user [13],
which can be an issue regarding speed and ease of use when
using the chatbot.
The chatbot format was also appreciated, as it could easily be
integrated into physicians’ routine practice, either during or
before a consultation with a patient. This was judged as
innovative since most chatbots in health care are developed to
provide information for patients [3-11]. Access to information
is also considered easier with a conversational agent than with
a classic drug reference database. First, it was considered to
provide reliable information in a practical way. Second, it made
information accessible so that physicians could quickly find
what they were looking for and, consequently, save time. In
that way, using a chatbot can improve medical care from
physicians’perspectives. Shared decision making may increase
the effectiveness of a treatment if the patient is given a sufficient
and appropriate amount of information [25]. In this regard, the
chatbot could help medical care.
It was pointed out that the conversational agent did not always
respond to the questions they formulated, either because it did
not recognize the everyday language employed by the users or
because the answers, while based on official regulatory
documents, were too broad without highlighting the most
important parts of information. However, they were aware that
the chatbot was still in an experimental stage. Regarding this
fact, most practitioners were willing to use the conversational
agent in its fully developed version if this tool remains easy to
use, secure, and easily accessible.
Areas of improvement for the conversational agent proposed
by medical practitioners included a better understanding of the
questions formulated, highlighting the most important
information, and better ergonomics.
Limitations
This market research is not without limitations. As an
exploratory study with a sample size of 10 medical practitioners,
findings are not generalizable to the entire population of medical
practitioners. This was a qualitative study conducted with
semistructured interviews, which allowed us to explore
tendencies and opinions on the usage of a conversational agent.
The average age of our sample (51.5 years) was slightly above
the average age of the medical practitioner population in France,
which was 50.8 years in 2018 [19]. The majority of our sample
was male practitioners (7/10, 70%), which does not reflect the
distribution between male (53%) and female (47%) medical
practitioners in France in 2018 [19].
In addition, medical practitioners who were recruited had already
participated in other digital epidemiological studies carried out
by the same research team, and it is possible that they were
more receptive to new health technology. In other words, while
our sampling method was not meant to be representative, this
specific market research may be prone to researcher bias.
Finally, because of the confidentiality policy, the drug associated
with the chatbot could not be cited in the paper. However, we
believe that it did not interfere with the results, which were
meant to elicit physicians’ perceptions of the chatbot.
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According to the results of this study, it appears that chatbots
could be a solution for quick and easily accessible information.
By reinforcing the knowledge on drugs based on official and
institutional recommendations, a chatbot could be used to
enhance compliance with the drug risk minimization measure
within the physician population. In particular, this chatbot
prototype was perceived by medical practitioners as a useful,
acceptable, innovative tool that could easily be integrated in
their daily medical practice. Finally, even though the chatbot
prototype could not be used as it was because of insufficient
information in the database, findings suggest that physicians
are willing to use a chatbot not only for prescription but also to
get information on drug interactions or to obtain assistance
within medical care for complex pathology or disease
management. A future challenge for the chatbot should be to
accommodate physicians’ needs for accurate, concise
information based on official regulatory documents that ensure
patients’ security.
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